JP2021511041A5 - - Google Patents
Info
- Publication number
- JP2021511041A5 JP2021511041A5 JP2020539264A JP2020539264A JP2021511041A5 JP 2021511041 A5 JP2021511041 A5 JP 2021511041A5 JP 2020539264 A JP2020539264 A JP 2020539264A JP 2020539264 A JP2020539264 A JP 2020539264A JP 2021511041 A5 JP2021511041 A5 JP 2021511041A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antigen
- car
- treg cells
- treg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18152631 | 2018-01-19 | ||
| EP18152631.0 | 2018-01-19 | ||
| PCT/EP2019/051143 WO2019141774A1 (en) | 2018-01-19 | 2019-01-17 | Regulatory t cell expressing a chimeric antigen receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511041A JP2021511041A (ja) | 2021-05-06 |
| JP2021511041A5 true JP2021511041A5 (enExample) | 2022-02-07 |
| JP7720148B2 JP7720148B2 (ja) | 2025-08-07 |
Family
ID=61027458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539264A Active JP7720148B2 (ja) | 2018-01-19 | 2019-01-17 | キメラ抗原受容体を発現する制御性ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12178872B2 (enExample) |
| EP (1) | EP3740569B1 (enExample) |
| JP (1) | JP7720148B2 (enExample) |
| KR (1) | KR102795692B1 (enExample) |
| CN (1) | CN111684061B (enExample) |
| CA (1) | CA3088832A1 (enExample) |
| ES (1) | ES2960686T3 (enExample) |
| WO (1) | WO2019141774A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111684061B (zh) | 2018-01-19 | 2024-07-30 | 美天施生物科技有限两合公司 | 表达嵌合抗原受体的调节性t细胞 |
| EP4013447A4 (en) * | 2019-08-16 | 2024-05-29 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | T CELLS EXPRESSING A CHIMERIC ANTI-CD83 ANTIGEN RECEPTOR |
| GB201912515D0 (en) * | 2019-08-30 | 2019-10-16 | King S College London | Engineered regulatory T cell |
| CN115066249A (zh) * | 2020-02-04 | 2022-09-16 | 美天施生物科技有限两合公司 | 表达用于感测可溶性抗原的适体嵌合抗原受体的免疫细胞 |
| JP7791096B2 (ja) | 2020-03-10 | 2025-12-23 | セラレス コーポレーション | 細胞処理のためのシステム、デバイス、及び方法 |
| CA3259305A1 (en) * | 2022-07-11 | 2024-01-18 | Sonoma Biotherapeutics, Inc. | RECOMBINANT CYTOKINE RECEPTORS AND METHODS OF USE |
| EP4683997A2 (en) | 2023-03-21 | 2026-01-28 | Cellares Corporation | Systems, devices, and methods for electroporation within a cell processing system |
| US12399193B2 (en) | 2023-05-05 | 2025-08-26 | Cellares Corporation | Systems, devices, and methods for combined cell processes |
| EP4467155A1 (en) * | 2023-05-23 | 2024-11-27 | Fundación para la Investigación Biomédica del Hospital Gregorio Marañón (FIBHGM) | Car-thytreg cells, compositions and uses thereof in immunotherapy |
| EP4735577A2 (en) | 2023-06-30 | 2026-05-06 | Cellares Corporation | Systems, devices, and methods for fluid transfer within an automated cell processing system |
| EP4766812A1 (en) | 2023-08-21 | 2026-07-01 | Cellares Corporation | FLUID REGULATION SYSTEMS, DEVICES AND METHODS IN A CELL PROCESSING SYSTEM |
| US12337321B2 (en) | 2023-08-21 | 2025-06-24 | Cellares Corporation | Systems, devices, and methods for automatic cell sorting |
| EP4766808A1 (en) | 2023-08-21 | 2026-07-01 | Cellares Corporation | BIOREACTORS AND THEIR PROCESSES OF USE IN AUTOMATIC CELL PROCESSING SYSTEMS |
| US12492368B2 (en) | 2024-03-11 | 2025-12-09 | Cellares Corporation | Monitoring air pressure within a cell processing system |
| WO2025202944A2 (en) | 2024-03-27 | 2025-10-02 | Cellares Corporation | Liquid level and flow rate detection within a cell processing system |
| USD1109621S1 (en) | 2024-04-15 | 2026-01-20 | Cellares Corporation | Analytical platform for biological material testing |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0211118D0 (en) | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
| GB0420466D0 (en) | 2004-09-14 | 2004-10-20 | Cassone Antonio | Anti-glucan antibodies |
| EP2520643B8 (en) | 2007-12-07 | 2019-11-27 | Miltenyi Biotec B.V. & Co. KG | Sample processing systems and methods |
| DE102009040716B4 (de) | 2009-09-10 | 2011-07-14 | Miltenyi Biotec GmbH, 51429 | Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen |
| JP5897035B2 (ja) | 2010-12-14 | 2016-03-30 | ユニバーシティ オブ メリーランド，ボルチモア | 汎用の抗タグキメラ抗原受容体発現ｔ細胞及びがんを治療する方法 |
| CN102153651B (zh) | 2011-01-21 | 2012-11-14 | 厦门大学 | 抗葡聚糖单链抗体及其制备方法 |
| CN122399016A (zh) * | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| PL3212225T3 (pl) | 2014-10-31 | 2026-03-30 | The Trustees Of The University Of Pennsylvania | Sposoby i kompozycje zmodyfikowanych limfocytów t |
| US20180251731A1 (en) | 2015-09-07 | 2018-09-06 | INSERM (Institute National de la Santé et de la Recherche Médicale) | Subpopulation of cd8+cd45rclow tregs and uses thereof |
| EP3368571B1 (en) | 2015-10-30 | 2022-12-07 | The Regents of The University of California | Transforming growth factor-beta-responsive polypeptides and their methods for use |
| CN109072194B (zh) | 2015-12-09 | 2022-12-27 | 纪念斯隆-凯特林癌症中心 | 免疫细胞组合物及其使用方法 |
| CN108697798A (zh) | 2016-02-16 | 2018-10-23 | 达纳-法伯癌症研究所有限公司 | 免疫疗法组合物及方法 |
| EP4086285A1 (en) | 2016-02-25 | 2022-11-09 | Cell Medica Switzerland AG | Binding members to pd-l1 |
| US20170274095A1 (en) * | 2016-03-23 | 2017-09-28 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced regulatory t cells targeted to sites of inflammation with chimeric antigen receptors and expressing factors that enhance viability of pancreatic cells |
| US10617720B2 (en) * | 2016-10-20 | 2020-04-14 | Miltenyi Biotech, GmbH | Chimeric antigen receptor specific for tumor cells |
| EP3336107A1 (en) * | 2016-12-15 | 2018-06-20 | Miltenyi Biotec GmbH | Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor |
| CN107557342A (zh) | 2017-11-02 | 2018-01-09 | 广东万海细胞生物科技有限公司 | 一种CAR‑Treg 细胞的制备方法及其应用 |
| CN111684061B (zh) | 2018-01-19 | 2024-07-30 | 美天施生物科技有限两合公司 | 表达嵌合抗原受体的调节性t细胞 |
| CN117693439A (zh) | 2021-07-28 | 2024-03-12 | 伊顿智能动力有限公司 | 自适应可控车辆逆变器系统和方法 |
-
2019
- 2019-01-17 CN CN201980009304.5A patent/CN111684061B/zh active Active
- 2019-01-17 KR KR1020207022067A patent/KR102795692B1/ko active Active
- 2019-01-17 US US16/962,755 patent/US12178872B2/en active Active
- 2019-01-17 ES ES19700530T patent/ES2960686T3/es active Active
- 2019-01-17 EP EP19700530.9A patent/EP3740569B1/en active Active
- 2019-01-17 WO PCT/EP2019/051143 patent/WO2019141774A1/en not_active Ceased
- 2019-01-17 CA CA3088832A patent/CA3088832A1/en active Pending
- 2019-01-17 JP JP2020539264A patent/JP7720148B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7387613B2 (ja) | 神経変性疾患及び障害の治療のためのキメラ抗原受容体 | |
| AU2018281316B2 (en) | Expression of novel cell tags | |
| RU2761557C2 (ru) | Способы культивирования клеток и наборы и устройство для них | |
| TWI792123B (zh) | 嵌合受體和使用彼之方法 | |
| Hendriks et al. | During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion | |
| KR102859521B1 (ko) | 지속 치료를 위한 나노입자 조성물 | |
| JP2025032089A (ja) | 腫瘍微小環境を標的とするキメラ抗原受容体 | |
| US11826385B2 (en) | Major histocompatibility complex-based chimeric receptors and uses thereof for treating autoimmune diseases | |
| JP2023027240A (ja) | 細胞の培養方法ならびにそのためのキットおよび装置 | |
| JP7566628B2 (ja) | キメラ抗原受容体を発現する免疫細胞 | |
| JP2016520074A5 (enExample) | ||
| CN118852404A (zh) | T细胞受体及其针对prame阳性癌症的免疫治疗 | |
| JP2024123133A (ja) | Ｔｎｆｒ２ドメインを含む新規ｃａｒ構築物 | |
| JP2018531035A6 (ja) | 細胞を培養するための方法ならびにそのためのキットおよび装置 | |
| JP2019532953A (ja) | 増強された有効性を有する免疫エフェクター細胞治療 | |
| KR20110099109A (ko) | 감염 및 종양 치료 방법 | |
| TW202206453A (zh) | 表現嵌合抗原受體之病毒特異性免疫細胞 | |
| US20200268796A1 (en) | Compositions and Methods for Treating Heart Disease via Redirected T Cell Immunotherapies | |
| CN111448215A (zh) | 抗-hla-a2抗体及其使用方法 | |
| JP2018524987A5 (enExample) | ||
| KR20090094380A (ko) | 감염 및 종양 치료를 위한 조성물 및 방법 | |
| CN111684061A (zh) | 表达嵌合抗原受体的调节性t细胞 | |
| JP2020526194A (ja) | 免疫療法薬と関連する毒性を評価するためのマウスモデル | |
| WO2020148769A1 (en) | Biomarker for cns disease modification | |
| JP2019513394A5 (enExample) |